Literature DB >> 8986497

Continuous arterial gas monitoring: initial experience with the Paratrend 7 in children.

I K Weiss1, S Fink, S Edmunds, R Harrison, K Donnelly.   

Abstract

OBJECTIVE: To describe clinical usage of the Paratrend 7 continuous arterial blood gas monitor in children.
DESIGN: Children older than 24 months of age who required significant ventilatory intervention were eligible for sensor placement.
INTERVENTIONS: The sensor was placed via the arterial catheter to measure pH, PCO2, PO2, and temperature. The simultaneous arterial blood gas value was recorded along with the sensor reading.
RESULTS: The sensor functioned for as long as seven days and provided the clinicians with data on the patient's respiratory status. The statistical validity of the device when compared to the arterial blood gas showed that the bias/precision for pH was 0.006/0.024, for PCO2 -0.78/4.68 mmHg, and for PO2 1.9%/17.1% (mmHg).
CONCLUSIONS: This report demonstrates actual clinical use of continuous blood gas monitoring in children. The information obtained is a major asset to the management of critically ill children in the intensive care unit.

Entities:  

Mesh:

Year:  1996        PMID: 8986497     DOI: 10.1007/bf01709562

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  13 in total

1.  Relationship between low-frequency oscillations of blood pressure and changes in arterial diameter.

Authors:  J P Siché; R De Gaudemaris; M Riachi; J M Mallion
Journal:  J Hypertens Suppl       Date:  1992-08

2.  Strategies of organization and service for the critical-care laboratory.

Authors:  M Fleisher; M K Schwartz
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue.

Authors:  O Larm; R Larsson; P Olsson
Journal:  Biomater Med Devices Artif Organs       Date:  1983

5.  Continuous intra-arterial blood gas and pH monitoring in critically ill patients with severe respiratory failure: a prospective, criterion standard study.

Authors:  M Haller; E Kilger; J Briegel; H Forst; K Peter
Journal:  Crit Care Med       Date:  1994-04       Impact factor: 7.598

6.  Clinical performance of a blood gas monitor: a prospective, multicenter trial.

Authors:  B A Shapiro; C K Mahutte; R D Cane; I J Gilmour
Journal:  Crit Care Med       Date:  1993-04       Impact factor: 7.598

7.  Reduction of blood loss from diagnostic sampling in critically ill patients using a blood-conserving arterial line system.

Authors:  M J Silver; Y H Li; L A Gragg; F Jubran; J K Stoller
Journal:  Chest       Date:  1993-12       Impact factor: 9.410

8.  Measurements of central blood vessels in infants and children: normal values.

Authors:  C Steinberg; D J Weinstock; J P Gold; D A Notterman
Journal:  Cathet Cardiovasc Diagn       Date:  1992-11

9.  The evaluation of a new intravascular blood gas monitoring system in the pig.

Authors:  T H Clutton-Brock; S Fink; D Markle; A J Luthra; S P Hendry
Journal:  J Clin Monit       Date:  1994-11

10.  A multiparameter sensor for continuous intra-arterial blood gas monitoring: a prospective evaluation.

Authors:  B Venkatesh; T H Clutton Brock; S P Hendry
Journal:  Crit Care Med       Date:  1994-04       Impact factor: 7.598

View more
  2 in total

1.  Continuous neonatal blood gas monitoring using a multiparameter intra-arterial sensor.

Authors:  C Morgan; S J Newell; D A Ducker; J Hodgkinson; D K White; C J Morley; J M Church
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

2.  Esophageal capnometry during hemorrhagic shock and after resuscitation in rats.

Authors:  Balagangadhar R Totapally; Harun Fakioglu; Dan Torbati; Jack Wolfsdorf
Journal:  Crit Care       Date:  2002-12-20       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.